HeartSciences Inc.
HSCS
$1.95
-$0.03-1.52%
NASDAQ
| 01/31/2026 | 10/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 26.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 26.32% | |||
| Cost of Revenue | -- | 25.00% | |||
| Gross Profit | -- | 27.27% | |||
| SG&A Expenses | -4.26% | 53.49% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.08% | 10.65% | |||
| Operating Income | 6.97% | -10.63% | |||
| Income Before Tax | 15.55% | -14.39% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 15.55% | -14.39% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 15.55% | -14.39% | |||
| EBIT | 6.97% | -10.63% | |||
| EBITDA | 6.99% | -10.68% | |||
| EPS Basic | 25.74% | 46.37% | |||
| Normalized Basic EPS | 25.74% | 46.37% | |||
| EPS Diluted | 25.74% | 46.37% | |||
| Normalized Diluted EPS | 25.74% | 46.37% | |||
| Average Basic Shares Outstanding | 13.73% | 113.31% | |||
| Average Diluted Shares Outstanding | 13.73% | 113.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||